Tag: safety reconciliation

KRIs, KPIs and Dashboards to Monitor Safety Reconciliation with EDC/Source Across Portfolios KRIs, KPIs and Dashboards to Monitor Safety Reconciliation with EDC/Source Across Portfolios The monitoring and management of safety in clinical trials is a critical aspect of research and regulatory compliance in the pharmaceutical and biopharmaceutical industries. Key Risk Indicators (KRIs), Key Performance Indicators…

Read More “KRIs, KPIs and Dashboards to Monitor Safety Reconciliation with EDC/Source Across Portfolios” »

Case Studies: Safety Reconciliation with EDC/Source That Strengthened Safety Oversight Case Studies: Safety Reconciliation with EDC/Source That Strengthened Safety Oversight Introduction to Safety Reconciliation in Clinical Trials In the realm of clinical trials, particularly within the framework of the clinical trial center, safety reconciliation has become a critical aspect of ensuring patient safety and data…

Read More “Case Studies: Safety Reconciliation with EDC/Source That Strengthened Safety Oversight” »

Common Pitfalls in Safety Reconciliation with EDC/Source—and How to Avoid Regulatory Findings In clinical research, the safety of trial participants is paramount. As biosimilar clinical trials expand, safety reconciliation between Electronic Data Capture (EDC) systems and source documents becomes increasingly complex. This guide aims to provide clinical operations, regulatory affairs, and medical affairs professionals with…

Read More “Common Pitfalls in Safety Reconciliation with EDC/Source—and How to Avoid Regulatory Findings” »

Aligning Safety Reconciliation with EDC/Source With GCP, ICH E2A–E2F and Local Regulations In the realm of clinical trials, timely and accurate safety reconciliation between Electronic Data Capture (EDC) systems and source documents is essential to meeting Good Clinical Practice (GCP) requirements as well as the stringent guidelines outlined in ICH E2A–E2F and local regulations. This…

Read More “Aligning Safety Reconciliation with EDC/Source With GCP, ICH E2A–E2F and Local Regulations” »

Digital Tools and Automation to Streamline Safety Reconciliation with EDC/Source Digital Tools and Automation to Streamline Safety Reconciliation with EDC/Source Safety reconciliation is a critical process in clinical trials that ensures the accurate reporting and management of adverse events (AEs) and serious adverse events (SAEs). As clinical trials evolve, especially in light of global efforts…

Read More “Digital Tools and Automation to Streamline Safety Reconciliation with EDC/Source” »

Safety Reconciliation with EDC/Source: End-to-End Compliance Framework for Global Clinical Trials In the fast-evolving landscape of clinical trials, especially in the realms governed by ICH-GCP, FDA, EMA, and MHRA regulations, the importance of safety reconciliation with Electronic Data Capture (EDC) and source data cannot be understated. This comprehensive guide aims to provide clinical operations, regulatory…

Read More “Safety Reconciliation with EDC/Source: End-to-End Compliance Framework for Global Clinical Trials” »

How to Design Safety Reconciliation with EDC/Source That Meets FDA, EMA and MHRA Expectations How to Design Safety Reconciliation with EDC/Source That Meets FDA, EMA and MHRA Expectations The design and implementation of effective safety reconciliation within clinical trials is crucial for ensuring participant safety and regulatory compliance. This step-by-step guide provides practical insights into…

Read More “How to Design Safety Reconciliation with EDC/Source That Meets FDA, EMA and MHRA Expectations” »

Safety Reconciliation with EDC/Source in Practice: Step-by-Step Guide for Sponsors and CROs Effective safety reconciliation is a critical aspect of clinical trials, particularly when it comes to managing adverse events (AEs) and serious adverse events (SAEs). For clinical research organization companies, ensuring accurate, efficient reconciliation between electronic data capture (EDC) systems and source documents is…

Read More “Safety Reconciliation with EDC/Source in Practice: Step-by-Step Guide for Sponsors and CROs” »